Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ward

Showing results (471-480 of 919) with videos related to

Pageof 92
Sort By:
The Journal of Allergy and Clinical Immunology|December 1, 1994
Investigating severe and fatal asthmaR S Call, G Ward, S Jackson, et al.
Scientific Reports|August 27, 2017
Stigmasterol prevents glucolipotoxicity induced defects in glucose-stimulated insulin secretionMeliza G Ward, Ge Li, Valéria C Barbosa-Lorenzi, et al.
Pharmacological Reviews|October 2, 2012
Inhibition of PI3K signaling spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignanciesJohn G Foster, Matthew D Blunt, Edward Carter, et al.
Annals of the New York Academy of Sciences|December 24, 1997
K+ induces an acid-labile phosphoenzyme (or an occluded Pi form) in Na,K-ATPaseJ D Cavieres, E Buxbaum, D G Ward, et al.
Diabetes|March 1, 1985
Gliclazide therapy is associated with potentiation of postbinding insulin action in obese, non-insulin-dependent diabetic subjectsG Ward, L C Harrison, J Proietto, et al.
Biochemical Society Transactions|May 1, 1997
Phorbol esters modulate the coupling of the T cell costimulatory molecule CD28 to phosphatidylinositol 3-kinaseR V Parry, G Boulougouris, D M Sansom, et al.
Cancer Control : Journal of the Moffitt Cancer Center|May 30, 2001
Fine-needle aspiration biopsy of sarcomas and related tumorsW G Ward, P Savage, C A Boles, et al.
International Immunopharmacology|February 6, 2007
Temporal variation in CB2R levels following T lymphocyte activation: evidence that cannabinoids modulate CXCL12-induced chemotaxisKaren Coopman, Laura D Smith, Karen L Wright, et al.
Journal of the American Society for Mass Spectrometry|January 23, 2016
A Novel Rapid MALDI-TOF-MS-Based Method for Measuring Urinary Globotriaosylceramide in Fabry PatientsFahad J Alharbi, Tarekegn Geberhiwot, Derralynn A Hughes, et al.
Translational Andrology and Urology|July 23, 2021
Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?Nada Humayun-Zakaria, Douglas G Ward, Roland Arnold, et al.
Pageof 92

Showing results (471-480 of 919) with videos related to

Sort By:
Pageof 92
The Journal of Allergy and Clinical Immunology|December 1, 1994
Investigating severe and fatal asthmaR S Call, G Ward, S Jackson, et al.
Scientific Reports|August 27, 2017
Stigmasterol prevents glucolipotoxicity induced defects in glucose-stimulated insulin secretionMeliza G Ward, Ge Li, Valéria C Barbosa-Lorenzi, et al.
Pharmacological Reviews|October 2, 2012
Inhibition of PI3K signaling spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignanciesJohn G Foster, Matthew D Blunt, Edward Carter, et al.
Annals of the New York Academy of Sciences|December 24, 1997
K+ induces an acid-labile phosphoenzyme (or an occluded Pi form) in Na,K-ATPaseJ D Cavieres, E Buxbaum, D G Ward, et al.
Diabetes|March 1, 1985
Gliclazide therapy is associated with potentiation of postbinding insulin action in obese, non-insulin-dependent diabetic subjectsG Ward, L C Harrison, J Proietto, et al.
Biochemical Society Transactions|May 1, 1997
Phorbol esters modulate the coupling of the T cell costimulatory molecule CD28 to phosphatidylinositol 3-kinaseR V Parry, G Boulougouris, D M Sansom, et al.
Cancer Control : Journal of the Moffitt Cancer Center|May 30, 2001
Fine-needle aspiration biopsy of sarcomas and related tumorsW G Ward, P Savage, C A Boles, et al.
International Immunopharmacology|February 6, 2007
Temporal variation in CB2R levels following T lymphocyte activation: evidence that cannabinoids modulate CXCL12-induced chemotaxisKaren Coopman, Laura D Smith, Karen L Wright, et al.
Journal of the American Society for Mass Spectrometry|January 23, 2016
A Novel Rapid MALDI-TOF-MS-Based Method for Measuring Urinary Globotriaosylceramide in Fabry PatientsFahad J Alharbi, Tarekegn Geberhiwot, Derralynn A Hughes, et al.
Translational Andrology and Urology|July 23, 2021
Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?Nada Humayun-Zakaria, Douglas G Ward, Roland Arnold, et al.
Pageof 92